Newer Combinations for the Treatment of CLL

Dr Linhares discusses newer combination therapies for the treatment of patients with chronic lymphocytic leukemia, highlighting ibrutinib and venetoclax, which is being studied in the CAPTIVATE trial.

Related Keywords

,Management Strategies ,Best Outcomes ,